isoproterenol has been researched along with Weight Loss in 13 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The goal of this study was to evaluate the contributions of oestrogen and weight loss to isoproterenol (isoprenaline; Iso)-induced Fos immunoreactivity (IR) and to angiotensin type 1 (AT1) receptor mRNA in forebrain regions implicated in the control of fluid balance." | 7.73 | Oestrogen and weight loss decrease isoproterenol-induced Fos immunoreactivity and angiotensin type 1 mRNA in the subfornical organ of female rats. ( Contreras, RJ; Curtis, KS; Krause, EG; Markle, JP; Stincic, TL, 2006) |
| " The goal of this study was to evaluate the contributions of oestrogen and weight loss to isoproterenol (isoprenaline; Iso)-induced Fos immunoreactivity (IR) and to angiotensin type 1 (AT1) receptor mRNA in forebrain regions implicated in the control of fluid balance." | 3.73 | Oestrogen and weight loss decrease isoproterenol-induced Fos immunoreactivity and angiotensin type 1 mRNA in the subfornical organ of female rats. ( Contreras, RJ; Curtis, KS; Krause, EG; Markle, JP; Stincic, TL, 2006) |
| " Basal lipolysis, maximal lipolytic responses to isoprenaline (beta-AR agonist), dobutamine and procaterol (beta1- and beta2-AR agonists, respectively) as well as maximal antilipolytic effects of epinephrine or UK-14304 (alpha2-AR agonist) were similar before and after weight reduction." | 3.70 | Regional and gender variations in adipose tissue lipolysis in response to weight loss. ( Alméras, N; Després, JP; Imbeault, P; Lacaille, M; Langin, D; Mauriège, P; Tremblay, A, 1999) |
| "We determined the effects of D-fenfluramine treatment on the changes in vascular reactivity induced by aging." | 3.68 | Effect of aging and drug-induced weight reduction on rat vascular reactivity. ( Boulanger, M; Duhault, J; Feletou, M; Moreau, N, 1993) |
| "Octopamine treatment resulted in a 19% decrease in body weight gain, when compared to the 177 g gained by controls during the same period." | 1.32 | Moderate weight-lowering effect of octopamine treatment in obese Zucker rats. ( Bour, S; Carpéné, C; Prévot, D; Visentin, V, 2003) |
| "Glycerol release was measured and used as a lipolytic index." | 1.30 | Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects. ( Hagström-Toft, E; Hellström, L; Reynisdottir, S; Rössner, S, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barakat, H | 1 |
| Hickner, RC | 1 |
| Privette, J | 1 |
| Bower, J | 1 |
| Hao, E | 1 |
| Udupi, V | 1 |
| Green, A | 1 |
| Pories, W | 1 |
| MacDonald, K | 1 |
| Berman, DM | 1 |
| Nicklas, BJ | 1 |
| Ryan, AS | 1 |
| Rogus, EM | 1 |
| Dennis, KE | 1 |
| Goldberg, AP | 1 |
| Bour, S | 1 |
| Visentin, V | 1 |
| Prévot, D | 1 |
| Carpéné, C | 2 |
| Krause, EG | 1 |
| Curtis, KS | 1 |
| Stincic, TL | 1 |
| Markle, JP | 1 |
| Contreras, RJ | 1 |
| Kaartinen, JM | 1 |
| LaNoue, KF | 1 |
| Martin, LF | 1 |
| Vikman, HL | 1 |
| Ohisalo, JJ | 1 |
| Feletou, M | 1 |
| Moreau, N | 1 |
| Boulanger, M | 1 |
| Duhault, J | 1 |
| Blaak, EE | 2 |
| van Baak, MA | 2 |
| Kester, AD | 1 |
| Saris, WH | 2 |
| Kemerink, GJ | 1 |
| Pakbiers, MT | 1 |
| Heidendal, GA | 1 |
| Greenway, FL | 1 |
| Bray, GA | 1 |
| Heber, D | 1 |
| Hellström, L | 1 |
| Rössner, S | 1 |
| Hagström-Toft, E | 1 |
| Reynisdottir, S | 1 |
| Mauriège, P | 1 |
| Imbeault, P | 1 |
| Langin, D | 1 |
| Lacaille, M | 1 |
| Alméras, N | 1 |
| Tremblay, A | 1 |
| Després, JP | 1 |
| Atgié, C | 1 |
| Le Gouic, S | 1 |
| Marti, L | 1 |
| Hanoun, N | 1 |
| Casteilla, L | 1 |
| Pénicaud, L | 1 |
| Ambid, L | 1 |
| Islam-Ali, B | 1 |
| Khan, S | 1 |
| Price, SA | 1 |
| Tisdale, MJ | 1 |
1 trial available for isoproterenol and Weight Loss
| Article | Year |
|---|---|
Topical fat reduction.
Topics: Adipose Tissue; Aminophylline; Colforsin; Female; Humans; Injections; Isoproterenol; Lipolysis; Oint | 1995 |
12 other studies available for isoproterenol and Weight Loss
| Article | Year |
|---|---|
Differences in the lipolytic function of adipose tissue preparations from Black American and Caucasian women.
Topics: Adipocytes; Adipose Tissue; Adrenergic beta-Agonists; Adult; Black People; Female; Humans; Isoproter | 2002 |
Regulation of lipolysis and lipoprotein lipase after weight loss in obese, postmenopausal women.
Topics: Adipocytes; Adipose Tissue; Adrenergic beta-Agonists; Aged; Body Composition; Cholesterol, HDL; Ener | 2004 |
Moderate weight-lowering effect of octopamine treatment in obese Zucker rats.
Topics: Adipocytes; Animals; Blood Glucose; Body Weight; Fatty Acids, Nonesterified; Food Deprivation; Gluco | 2003 |
Oestrogen and weight loss decrease isoproterenol-induced Fos immunoreactivity and angiotensin type 1 mRNA in the subfornical organ of female rats.
Topics: Animals; Drinking; Drug Interactions; Estrogens; Female; Immunohistochemistry; In Situ Hybridization | 2006 |
Beta-adrenergic responsiveness of adenylate cyclase in human adipocyte plasma membranes in obesity and after massive weight reduction.
Topics: Adenylyl Cyclases; Adipose Tissue; Adult; Analysis of Variance; Cell Fractionation; Cell Membrane; F | 1995 |
Effect of aging and drug-induced weight reduction on rat vascular reactivity.
Topics: Administration, Oral; Aging; Animals; Aorta; Blood Glucose; Body Weight; Endothelium, Vascular; Fenf | 1993 |
Beta-adrenergically mediated thermogenic and heart rate responses: effect of obesity and weight loss.
Topics: Adult; Body Temperature Regulation; Energy Metabolism; Heart Rate; Humans; Isoproterenol; Male; Nore | 1995 |
beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Body Composition; Fatty Acid | 1994 |
Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
Topics: Adenosine Deaminase; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Bio | 1997 |
Regional and gender variations in adipose tissue lipolysis in response to weight loss.
Topics: Adenosine Deaminase; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Dob | 1999 |
Lipolytic and antilipolytic responses of the Siberian hamster (Phodopus sungorus sungorus) white adipocytes after weight loss induced by short photoperiod exposure.
Topics: Adipocytes; Adipose Tissue; Adrenergic beta-Agonists; Adrenocorticotropic Hormone; Animals; Cricetin | 1998 |
Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF).
Topics: Adenylyl Cyclases; Adipocytes; Animals; Appetite Depressants; Cachexia; Cell Membrane; Colforsin; Ei | 2001 |